Results 171 to 180 of about 37,247 (250)
Redefining ALS: Large-scale proteomic profiling reveals a prolonged pre-diagnostic phase with immune, muscular, metabolic, and brain involvement
Homann J, Korologou-Linden R, Viallon V, Morgan S, Dobricic V, Deecke L, Schessner JP, Smith-Byrne K, Birtles D, Zhao Y, Wuu J, Artaud F, Hajizadah F, Huerta JM, Ohlei O, Lebedev M, Kolijn PM, Guevara M, Jimenez-Zabala A, Sánchez MJ, Trobajo-Sanmartín C, Colorado-Yohar SM, Alonso-Martín S, Petrova D, Sieri S, Berger K, Peters S, Wareham N, Kaaks R, Travis RC, Vermeulen RCH, The Global Neurodegeneration Proteomics Consortium (GNPC), Tzoulaki I, Elbaz A, Mann M, Sacerdote C, Masala G, Katzke V, Benatar M, Bertram L, Middleton L, Riboli E, Gunter MJ, Ferrari P, Robinson O, Lill CM. +45 moreeuropepmc +2 more sourcesHealthy lifestyle change and all-cause and cancer mortality in the European Prospective Investigation into Cancer and Nutrition cohort. [PDF]
BMC MedMatta K, Viallon V, Botteri E, Peveri G, Dahm C, Nannsen AØ, Olsen A, Tjønneland A, Elbaz A, Artaud F, Marques C, Kaaks R, Katzke V, Schulze MB, Llanaj E, Masala G, Pala V, Panico S, Tumino R, Ricceri F, Derksen JWG, Nøst TH, Sandanger TM, Borch KB, Quirós JR, Castro-Espin C, Sánchez MJ, Atxega AA, Cirera L, Guevara M, Manjer J, Tin Tin S, Heath A, Touvier M, Goldberg M, Weiderpass E, Gunter MJ, Freisling H, Riboli E, Ferrari P. +39 moreeuropepmc +1 more sourceIs COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals. [PDF]
Adv TherSpinner CD, Bell S, Einsele H, Tremblay C, Goldman M, Chagla Z, Finckh A, Edwards CJ, Aurer I, Launay O, Casañas I Comabella C, James S, Dube S, Borkowska K, Jah F, Kandeil W, Yokota RTC, Artaud C, Gottenberg JE, Gesualdo L, Bertrand D, Arnetorp S, Magiorkinis G. +22 moreeuropepmc +1 more sourceLong Covid: a global health issue - a prospective, cohort study set in four continents. [PDF]
BMJ Glob HealthPazukhina E, Garcia-Gallo E, Reyes LF, Kildal AB, Jassat W, Dryden M, Holter JC, Chatterjee A, Gomez K, Søraas A, Puntoni M, Latronico N, Bozza FA, Edelstein M, Gonçalves BP, Kartsonaki C, Kruglova O, Gaião S, Chow YP, Doshi Y, Duque Vallejo SI, Ibáñez-Prada ED, Fuentes YV, Hastie C, O'Hara ME, Balan V, Menkir T, Merson L, Kelly S, Citarella BW, Semple MG, Scott JT, Munblit D, Sigfrid L, ISARIC Clinical Characterisation Group and ISARIC Global Covid-19 follow up working group. +34 moreeuropepmc +1 more source
